Submitting Next Generation Sequencing Data to the Division of Antiviral Products Guidance for Industry Technical Specifications Document
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Clinical - Antimicrobial
Published
July 18, 2019
Last updated
May 5, 2020
Description
Guidance document on submitting Next Generation Sequencing data to the Division of Antiviral Products, focusing on Clinical - Antimicrobial topics.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)